You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

BENZPHETAMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Benzphetamine Hydrochloride patents expire, and when can generic versions of Benzphetamine Hydrochloride launch?

Benzphetamine Hydrochloride is a drug marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, and Tedor Pharm. and is included in nine NDAs.

The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Benzphetamine Hydrochloride

A generic version of BENZPHETAMINE HYDROCHLORIDE was approved as benzphetamine hydrochloride by KVK TECH on July 20th, 2010.

  Try a Trial

US Patents and Regulatory Information for BENZPHETAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet Lifesciences BENZPHETAMINE HYDROCHLORIDE benzphetamine hydrochloride TABLET;ORAL 202061-001 Jan 27, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Kvk Tech BENZPHETAMINE HYDROCHLORIDE benzphetamine hydrochloride TABLET;ORAL 090968-001 Jul 20, 2010 AA RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc BENZPHETAMINE HYDROCHLORIDE benzphetamine hydrochloride TABLET;ORAL 040714-001 Oct 29, 2007 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Scinopharm Taiwan BENZPHETAMINE HYDROCHLORIDE benzphetamine hydrochloride TABLET;ORAL 040578-001 Apr 17, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.